|
DCAF5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.939800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55427999999347E-05 |
| Normal-vs-Stage2 |
3.797600E-01 |
| Normal-vs-Stage3 |
2.779400E-01 |
| Normal-vs-Stage4 |
7.860000E-01 |
| Stage1-vs-Stage2 |
9.094300E-02 |
| Stage1-vs-Stage3 |
1.648060E-02 |
| Stage1-vs-Stage4 |
8.811300E-04 |
| Stage2-vs-Stage3 |
9.252200E-01 |
| Stage2-vs-Stage4 |
3.541000E-01 |
| Stage3-vs-Stage4 |
2.947800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.961800E-03 |
| Normal-vs-AfricanAmerican |
1.338750E-01 |
| Normal-vs-Asian |
2.09860000000006E-06 |
| Caucasian-vs-AfricanAmerican |
9.013800E-01 |
| Caucasian-vs-Asian |
3.011700E-02 |
| AfricanAmerican-vs-Asian |
5.164300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.960200E-02 |
| Normal-vs-Female |
2.606300E-04 |
| Male-vs-Female |
5.389700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.312800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.59040000000355E-05 |
| Normal-vs-Age(61-80Yrs) |
2.102200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.834600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.433600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.378600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.599200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.739800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.032600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.455600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.98490113234584E-11 |
| Normal-vs-Grade 2 |
1.95929999999844E-05 |
| Normal-vs-Grade 3 |
2.819000E-01 |
| Normal-vs-Grade 4 |
6.367400E-01 |
| Grade 1-vs-Grade 2 |
3.159500E-03 |
| Grade 1-vs-Grade 3 |
1.93003999999775E-05 |
| Grade 1-vs-Grade 4 |
7.72239999999869E-05 |
| Grade 2-vs-Grade 3 |
1.576470E-03 |
| Grade 2-vs-Grade 4 |
8.759200E-04 |
| Grade 3-vs-Grade 4 |
2.186400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71794999999086E-05 |
| Normal-vs-ccB subtype |
8.642300E-02 |
| ccA subtype-vs-ccB subtype |
3.571700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.418700E-03 |
| Normal-vs-N1 |
4.269900E-02 |
| N0-vs-N1 |
6.522900E-03 |
|
|
